Clinical Trial

Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2

Study acronym: MATADOR2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is an interventional, prospective, single-center study designed to collect and describe genetic, environmental and psychosocial control data from male participants. The participants did not have any prior history of cancer at the time of the oncogenetic consultation and do not have the family mutation researched during the oncogenetic consultation (targeted genetic testing). The participants are referenced in the IUCT-O medical records as family members of patients suffering from male breast cancer. The study will be conducted on a population of 120 participants.
Trial Details
NCT Number NCT07558343
Lead Sponsor Institut Claudius Regaud
Collaborators: Ligue contre le cancer, France
Conditions Male Breast Cancer
Enrollment 120 participants
Start Date 2026-06-15
Primary Completion 2027-07-15 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-30